,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,167929,4,3,,103288464,22469,Unspecified,,,,,Carcinogenic activity on all sites after subcutaneous administration,Other,7265110.0,
1,167943,4,3,,103288464,22469,Unspecified,,,,,Carcinogenic activity on breast after subcutaneous administration,Other,7265110.0,
2,167957,4,3,,103288464,22469,Unspecified,,,,,Carcinogenic activity on ear duct after subcutaneous administration,Other,7265110.0,
3,168091,3,3,,103288464,22469,Unspecified,,,,,Carcinogenic activity on liver after subcutaneous administration,Other,7265110.0,
4,168115,3,3,,103288464,22469,Unspecified,,,,,Carcinogenic activity on other sites after subcutaneous administration,Other,7265110.0,
5,1259407,1,1,,363898679,22469,Active,,,,,CCRIS mutagenicity studies,Other,,
6,1259408,1,1,,363896447,22469,Active,,,,,GENE-TOX mutagenicity studies,Other,,
